Indian Rival Meril Accuses Edwards Lifesciences Of Anti-Competitive Behavior In EU Antitrust Complaint
Indian Rival Meril Accuses Edwards Lifesciences Of Anti-Competitive Behavior In EU Antitrust Complaint
On Monday, U.S. heart valve manufacturer Edwards Lifesciences Corporation (NYSE:EW) faced an EU antitrust complaint from Indian competitor Meril, alleging anti-competitive behavior, particularly concerning patents.
周一，美国心脏瓣膜制造商爱德华兹生命科学公司（纽约证券交易所代码：EW）面临来自印度竞争对手梅里尔的欧盟反垄断投诉，指控其存在反竞争行为，特别是在专利方面。
This could potentially intensify EU regulators' scrutiny of Edwards, Reuters reports.
路透社报道，这可能会加强欧盟监管机构对爱德华兹的审查。
Recent regulatory actions in the United States and Europe aim to promote fair competition and maintain drug and product affordability, especially for smaller innovative companies challenging larger incumbents.
美国和欧洲最近的监管行动旨在促进公平竞争，保持药品和产品的可负担性，特别是对挑战大型现有企业的小型创新公司而言。
Meril has formally complained to the European Commission, citing longstanding disputes over heart valve patents spanning various global jurisdictions.
梅里尔已正式向欧盟委员会投诉，理由是关于心脏瓣膜专利的长期争议横跨全球各个司法管辖区。
Renowned for its transcatheter aortic valve replacement (TAVR) device, Edwards Lifesciences underwent an EU antitrust probe last year amid concerns about potential market dominance abuses.
Edwards Lifesciences以其经导管主动脉瓣置换术（TAVR）设备而闻名，由于担心可能滥用市场主导地位，去年接受了欧盟的反垄断调查。
The core of Meril's grievance centers on Edwards' global unilateral pro-innovation policy, which Meril claims obstructs engagement with entities labeled as patent copiers.
梅里尔申诉的核心集中在爱德华兹的全球单边支持创新政策上，梅里尔声称该政策阻碍了与被贴上专利复印商标签的实体的合作。
Additionally, Meril accuses Edwards of employing tactics such as evergreening and patent thickets, extending patent protections and creating barriers to entry for competitors.
此外，梅里尔指责爱德华兹采取诸如常绿化和专利灌木丛等策略，扩大专利保护，为竞争对手设置进入壁垒。
Edwards denies Meril's accusations, citing successful injunctions against Meril's Myval system in seven countries and the Unified Patent Court.
爱德华兹否认了梅里尔的指控，理由是在七个国家成功地对梅里尔的Myval系统和统一专利法院下达了禁令。
The company asserts that Meril substantially copied its technology rather than engaging in fair competition.
该公司断言，Meril实质性地复制了其技术，而不是参与公平竞争。
In a regulatory filing from February, Edwards disclosed that the European Commission is investigating certain business practices, including its anti-copycat policy and patent strategies.
爱德华兹在二月份的一份监管文件中透露，欧盟委员会正在调查某些商业行为，包括其反模仿政策和专利战略。
Meril alleges that Edwards has launched a disparagement campaign to undermine its intellectual property rights and is currently undergoing patent litigation.
梅里尔声称，爱德华兹发起了一场贬低运动，以破坏其知识产权，目前正在进行专利诉讼。
Price Action: EW shares are up 1.24% at $85.75 at last check Tuesday.
价格走势：周二最后一次检查时，EW股价上涨1.24％，至85.75美元。
Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
免责声明：此内容部分是在人工智能工具的帮助下制作的，并由Benzinga的编辑审阅和发布。
Photo via Wikimedia Commons
照片来自维基共享资源
译文内容由第三方软件翻译。